What's breaking now, across thousands of outlets.
(MedPage Today) -- Many patients treated with golimumab (Simponi) for newly diagnosed peripheral spondyloarthritis (pSpA) in a small trial achieved sustained drug-free remission after 10 years of follow-up, researchers found. With 49 of the trial...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
A delegation from Washington State in the United States has paid a courtesy call on the Ghana Medical Trust Fund (GMTF) to explore opportunities for partnership and collaboration in healthcare…
For years, thousands of residents in Mwea, Kirinyaga County, relied on irrigation canals for drinking, cooking, washing and other household needs, exposing families to contaminated water and…
Saudi Arabia does not require Pakistani Umrah pilgrims to receive a seasonal influenza vaccine, according to the kingdom’s official health … Read More The post Questions Raised Over Umrah Vaccination…
Roche is entering two fresh partnerships with drug discovery biotechs Atavistik Bio and Earendil Labs to develop new candidates, in a continuation of the Swiss drugmaker’s dealmaking blitz.
A medicine acquired in a $1.3 billion buyout came through in the first of two pivotal studies in diabetic macular edema, though language regarding the drug’s safety stirred debate among analysts.
Dr. Heidi Overton is appearing before a Senate committee on Thursday for her confirmation hearing as the next commissioner of the Food and Drug Administration.
